Recombinant Costimulatory Fusion Proteins as Functional Immunomodulators Enhance Antitumor Activity in Murine B16F10 Melanoma
Blocking inhibitory signaling and engaging stimulatory signaling have emerged as important therapeutic modalities for cancer immunotherapy. This study aimed to investigate immunomodulatory features of three recombinant costimulatory ligand proteins in a mouse model, which are extracellular domains o...
Main Authors: | Huaman Cai, Wenfang Wang, Zhibing Lin, Yan Zhang, Bing Wu, Yuhua Wan, Rongxiu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/2/223 |
Similar Items
-
Role of OX40 and its ligand as costimulatory modulators in cancer immunotherapy
by: Aliya I Sani, et al.
Published: (2021-07-01) -
Boosting antitumor response with PSMA-targeted immunomodulatory VLPs, harboring costimulatory TNFSF ligands and GM-CSF cytokine
by: Soledad Palameta, et al.
Published: (2022-03-01) -
Activation of OX40 and CD27 Costimulatory Signalling in Sheep through Recombinant Ovine Ligands
by: José Manuel Rojas, et al.
Published: (2020-06-01) -
Fundamental Characterization of Antibody Fusion-Single-Chain TNF Recombinant Proteins Directed against Costimulatory TNF Receptors Expressed by T-Lymphocytes
by: Hodaka Nagai, et al.
Published: (2023-06-01) -
OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis—Focus on Rocatinlimab and Amlitelimab
by: Ana Maria Lé, et al.
Published: (2022-12-01)